98 related articles for article (PubMed ID: 16571772)
1. In vivo overexpression of Flt3 ligand expands and activates murine spleen natural killer dendritic cells.
Chaudhry UI; Katz SC; Kingham TP; Pillarisetty VG; Raab JR; Shah AB; DeMatteo RP
FASEB J; 2006 May; 20(7):982-4. PubMed ID: 16571772
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
Liu Y; Huang H; Chen Z; Zong L; Xiang J
J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636
[TBL] [Abstract][Full Text] [Related]
3. Combined stimulation with interleukin-18 and CpG induces murine natural killer dendritic cells to produce IFN-gamma and inhibit tumor growth.
Chaudhry UI; Kingham TP; Plitas G; Katz SC; Raab JR; DeMatteo RP
Cancer Res; 2006 Nov; 66(21):10497-504. PubMed ID: 17079471
[TBL] [Abstract][Full Text] [Related]
4. Murine Flt3 ligand expands distinct dendritic cells with both tolerogenic and immunogenic properties.
Miller G; Pillarisetty VG; Shah AB; Lahrs S; DeMatteo RP
J Immunol; 2003 Apr; 170(7):3554-64. PubMed ID: 12646617
[TBL] [Abstract][Full Text] [Related]
5. Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-gamma via autocrine IL-12.
Pillarisetty VG; Katz SC; Bleier JI; Shah AB; Dematteo RP
J Immunol; 2005 Mar; 174(5):2612-8. PubMed ID: 15728467
[TBL] [Abstract][Full Text] [Related]
6. NK dendritic cells expanded in IL-15 exhibit antitumor responses in vivo.
Chaudhry UI; Plitas G; Burt BM; Kingham TP; Raab JR; DeMatteo RP
J Immunol; 2007 Oct; 179(7):4654-60. PubMed ID: 17878363
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-21 expanded NKDC in vitro reduces the B16F10 tumor growth in vivo.
Souza AP; Bonorino C; Muraro SP; Rodrigues LC
Cytokine; 2013 Jan; 61(1):154-60. PubMed ID: 23098768
[TBL] [Abstract][Full Text] [Related]
8. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells.
McKenna HJ; Stocking KL; Miller RE; Brasel K; De Smedt T; Maraskovsky E; Maliszewski CR; Lynch DH; Smith J; Pulendran B; Roux ER; Teepe M; Lyman SD; Peschon JJ
Blood; 2000 Jun; 95(11):3489-97. PubMed ID: 10828034
[TBL] [Abstract][Full Text] [Related]
9. Immunization with wild-type p53 gene sequences coadministered with Flt3 ligand induces an antigen-specific type 1 T-cell response.
Parajuli P; Pisarev V; Sublet J; Steffel A; Varney M; Singh R; LaFace D; Talmadge JE
Cancer Res; 2001 Nov; 61(22):8227-34. PubMed ID: 11719454
[TBL] [Abstract][Full Text] [Related]
10. Murine liver plasmacytoid dendritic cells become potent immunostimulatory cells after Flt-3 ligand expansion.
Kingham TP; Chaudhry UI; Plitas G; Katz SC; Raab J; DeMatteo RP
Hepatology; 2007 Feb; 45(2):445-54. PubMed ID: 17256750
[TBL] [Abstract][Full Text] [Related]
11. In vitro tumor-pulsed or in vivo Flt3 ligand-generated dendritic cells provide protection against acute myelogenous leukemia in nontransplanted or syngeneic bone marrow-transplanted mice.
Pawlowska AB; Hashino S; McKenna H; Weigel BJ; Taylor PA; Blazar BR
Blood; 2001 Mar; 97(5):1474-82. PubMed ID: 11222396
[TBL] [Abstract][Full Text] [Related]
12. NK dendritic cells are innate immune responders to Listeria monocytogenes infection.
Plitas G; Chaudhry UI; Kingham TP; Raab JR; DeMatteo RP
J Immunol; 2007 Apr; 178(7):4411-6. PubMed ID: 17371998
[TBL] [Abstract][Full Text] [Related]
13. Spleen but not tumor infiltration by dendritic and T cells is increased by intravenous adenovirus-Flt3 ligand injection.
Solheim JC; Reber AJ; Ashour AE; Robinson S; Futakuchi M; Kurz SG; Hood K; Fields RR; Shafer LR; Cornell D; Sutjipto S; Zurawski S; LaFace DM; Singh RK; Talmadge JE
Cancer Gene Ther; 2007 Apr; 14(4):364-71. PubMed ID: 17235356
[TBL] [Abstract][Full Text] [Related]
14. Immunostimulatory effect of Fms-like tyrosine kinase 3 ligand on peripheral monocyte-derived dendritic cells and natural killer cells: utilization for ovarian cancer treatment.
Matsumura N; Mandai M; Hamanishi J; Yamaguchi K; Fukuhara K; Yagi H; Higuchi T; Takakura K; Fujii S
Oncol Rep; 2008 Feb; 19(2):505-15. PubMed ID: 18202801
[TBL] [Abstract][Full Text] [Related]
15. Regulation of dendritic cell expansion in aged athymic nude mice by FLT3 ligand.
Shurin GV; Chatta GS; Tourkova IL; Zorina TD; Esche C; Shurin MR
Exp Gerontol; 2004 Mar; 39(3):339-48. PubMed ID: 15036393
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of intestinal Peyer's patch interferon-alpha producing (plasmacytoid) dendritic cells.
Castellaneta A; Abe M; Morelli AE; Thomson AW
Hum Immunol; 2004 Feb; 65(2):104-13. PubMed ID: 14969765
[TBL] [Abstract][Full Text] [Related]
17. Natural killer dendritic cells are an intermediate of developing dendritic cells.
Chen L; Calomeni E; Wen J; Ozato K; Shen R; Gao JX
J Leukoc Biol; 2007 Jun; 81(6):1422-33. PubMed ID: 17332372
[TBL] [Abstract][Full Text] [Related]
18. Flt3L-mobilized dendritic cells bearing H2-Kbm1 apoptotic cells do not induce cross-tolerance to CD8+ T cells across a class I MHC mismatched barrier.
del Rio ML; Cote-Sierra J; Rodriguez-Barbosa JI
Transpl Int; 2011 May; 24(5):501-13. PubMed ID: 21276089
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-SCF.
Daro E; Butz E; Smith J; Teepe M; Maliszewski CR; McKenna HJ
Cytokine; 2002 Feb; 17(3):119-30. PubMed ID: 11895330
[TBL] [Abstract][Full Text] [Related]
20. MUC1 epithelial mucin (CD227) is expressed by activated dendritic cells.
Wykes M; MacDonald KP; Tran M; Quin RJ; Xing PX; Gendler SJ; Hart DN; McGuckin MA
J Leukoc Biol; 2002 Oct; 72(4):692-701. PubMed ID: 12377938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
